The Latest Breakthroughs in mHSPC
AUAUniversity24 Syys 2025

The Latest Breakthroughs in mHSPC

The Latest Breakthroughs in mHSPC CME Available: https://auau.auanet.org/node/43825 After participating in this CME activity, participants will be able to: 1.Evaluate the concept of personalized therapy and its importance in the treatment of de novo mHSPC. 2.Implement current clinical guidelines for biomarker testing in mHSPC. 3.Explain the role of the PI3K/AKT pathway in prostate cancer biology. 4.Explore collaborations between urologists, oncologists, radiologists, and other healthcare professionals in managing de novo mHSPC. 5.Employ strategies to manage and mitigate common adverse events associated with AKT inhibitors and other therapies used in mHSPC. Acknowledgements: AstraZeneca Bayer HealthCare Pharmaceuticals Inc.

Jaksot(428)

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
rss-narsisti
adhd-podi
rahapuhetta
rss-rahamania
kesken
psykologia
rss-liian-kuuma-peruna
rss-niinku-asia-on
esa-saarinen-filosofia-ja-systeemiajattelu
rss-eron-alkemiaa
rss-luonnollinen-synnytys-podcast
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-duodecim-lehti
rss-koira-haudattuna
rss-vapaudu-voimaasi
rss-valo-minussa-2
rss-finnish-daily-dialogues